165 related articles for article (PubMed ID: 32304873)
21. Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.
Bhatt VR; Loberiza FR; Jing H; Bociek RG; Bierman PJ; Maness LJ; Vose JM; Armitage JO; Akhtari M
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):409-415.e1. PubMed ID: 25816932
[TBL] [Abstract][Full Text] [Related]
22. Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients.
Rodríguez-Lobato LG; Martínez-Roca A; Moreno DF; Gutiérrez-García G; Suárez-Lledó M; Rovira M; Martínez C; Rosiñol L; Almeida Jorge AS; Pedraza A; Cardozo C; Puerta-Alcalde P; Garcia-Vidal C; Marín P; Cid J; Lozano M; Gallego C; Hernando A; Segura S; Urbano-Ispizua Á; Fernández-Avilés F
Leuk Lymphoma; 2020 Jul; 61(7):1565-1574. PubMed ID: 32208787
[TBL] [Abstract][Full Text] [Related]
23. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
24. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
Copeland V; McLaughlin M; Trifilio S
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29080369
[TBL] [Abstract][Full Text] [Related]
25. Impact of fluoroquinolone administration and gut mucosal colonization on the risk of pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation.
Akhmedov M; Klyasova G; Kuzmina L; Fedorova A; Drokov M; Parovichnikova E
Leuk Lymphoma; 2023 Jun; 64(6):1102-1111. PubMed ID: 37086466
[TBL] [Abstract][Full Text] [Related]
26. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
[TBL] [Abstract][Full Text] [Related]
27. Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.
Sun L; Li S; El-Jawahri A; Armand P; Dey BR; Fisher DC; Jacobsen ED; Jacobson CA; LaCasce AS; McAfee SL; Spitzer TR; Chen YB; DeFilipp Z
Oncologist; 2018 May; 23(5):624-630. PubMed ID: 29284757
[TBL] [Abstract][Full Text] [Related]
28. Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.
Modi D; Jang H; Kim S; Surapaneni M; Sankar K; Deol A; Ayash L; Bhutani D; Lum LG; Ratanatharathorn V; Manasa R; Mellert K; Chandrasekar P; Uberti JP
Support Care Cancer; 2017 Aug; 25(8):2593-2601. PubMed ID: 28365897
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic hematopoietic cell transplantation without fluconazole and fluoroquinolone prophylaxis.
Heidenreich D; Kreil S; Nolte F; Reinwald M; Hofmann WK; Klein SA
Ann Hematol; 2016 Jan; 95(2):287-93. PubMed ID: 26494235
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation.
Mürner CM; Stenner-Liewen F; Seifert B; Mueller NJ; Schmidt A; Renner C; Schanz U; Knuth A; Manz MG; Scharl M; Gerber B; Samaras P
Leuk Lymphoma; 2019 Mar; 60(3):685-695. PubMed ID: 30126310
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
Oliver AC; Riva E; Mosquera R; Galeano S; Pierri S; Bello L; Caneiro A; Gai R; Miller A; Muxi P
Ann Hematol; 2020 Apr; 99(4):877-884. PubMed ID: 32062742
[TBL] [Abstract][Full Text] [Related]
32. Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes.
Mohan M; Susanibar-Adaniya S; Buros A; Crescencio JCR; Burgess MJ; Lusardi K; Davies F; Morgan G; Vanrhee F; Zangari M; Schinke C; Thanendrarajan S; Kothari A
Transpl Infect Dis; 2019 Apr; 21(2):e13052. PubMed ID: 30689291
[TBL] [Abstract][Full Text] [Related]
33. Bacteraemia post-autologous haematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decade's experience from Lebanon.
Moghnieh R; Abdallah D; Awad L; Jisr T; Mugharbil A; Youssef A; Tamim H; Khaldieh S; Massri O; Rashini N; Hamdan Y; Ibrahim A
Infection; 2018 Dec; 46(6):823-835. PubMed ID: 30143988
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
Klein EM; Sauer S; Klein S; Tichy D; Benner A; Bertsch U; Brandt J; Kimmich C; Goldschmidt H; Müller-Tidow C; Jordan K; Giesen N
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298654
[TBL] [Abstract][Full Text] [Related]
35. Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) - a single-center experience.
Wolska A; Robak T; Szmigielska-Kaplon A; Pluta A; Kopka P; Wierzbowska A
Adv Med Sci; 2012 Jun; 57(1):118-23. PubMed ID: 22366265
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
[TBL] [Abstract][Full Text] [Related]
37. Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR; Graiser M; Heffner LT; Lonial S; Nooka AK
Cancer; 2019 Jan; 125(2):185-193. PubMed ID: 30480777
[TBL] [Abstract][Full Text] [Related]
38. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
Mikulska M; Averbuch D; Tissot F; Cordonnier C; Akova M; Calandra T; Ceppi M; Bruzzi P; Viscoli C;
J Infect; 2018 Jan; 76(1):20-37. PubMed ID: 29079323
[TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
